Consumption effect of a synbiotic beverage made from soy and yacon extracts containing Bifidobacterium animalis ssp. lactis BB-12 on the intestinal polyamine concentrations in elderly individuals.
- 2017-09
- Food Research International 99
- M. Manzoni
- E. Rossi
- N. D. Pauly-Silveira
- R. A. Pinto
- M. N. Roselino
- I. Carlos
- M. B. Quilles
- Maria Beatriz de Abreu Glória
- D. Cavallini
- PubMed: 28784510
- DOI: 10.1016/j.foodres.2017.06.005
Abstract
This study aimed to investigate the effect of a synbiotic beverage made from soy and yacon (Smallanthus sonchifolius) extracts containing Bifidobacterium animalis ssp. lactis BB-12 on healthy elderly individuals' intestinal polyamine concentrations. A randomized, double-blinded, placebo-controlled trial has been conducted with twenty-nine volunteers (over 65years of age) who either had a daily intake of 150mL of synbiotic (synbiotic group - S) or placebo (placebo group - P) beverages. Both had the same nutrient composition, except that a probiotic culture was added to the synbiotic beverage. Total experiment time was 8weeks, which was divided into 3 consecutive phases: a prefeeding period (2weeks), followed by a feeding period (4weeks) and a postfeeding period (2weeks). Stool samples were collected at 3 time periods. Fecal concentrations of polyamines, putrescine (PUT), cadaverine (CAD) and spermidine (SPD) that were obtained during the synbiotic and placebo consumption period were significantly higher (p<0.05) than those found during the pre-consumption baseline level period. No significant differences in the number of bifidobacteria, clostridia, or enterobacteria were observed in any of the two groups at the three time periods. Similarly, no significant effect on the production of proinflammatory cytokines tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6) and anti-inflammatory interleukin-10 (IL-10) was induced by the synbiotic or placebo beverages consumption. The results herein indicate that both the synbiotic and the placebo beverage consumption have increased polyamines levels, which are often reduced in elderly individuals, without influencing inflammatory responses. In addition, both placebo and synbiotic beverages seems to contribute by maintaining increased polyamines levels.
Keywords: Bifidobacterium; Elderly; Gut environment; Polyamine; Soy; Yacon.
Research Insights
Supplement | Health Outcome | Effect Type | Effect Size |
---|---|---|---|
Bifidobacterium | Increased Intestinal Polyamine Levels | Beneficial | Moderate |
Bifidobacterium | Stable Inflammatory Responses | Neutral | Small |
Bifidobacterium animalis | Increased Intestinal Polyamine Levels | Beneficial | Moderate |
Bifidobacterium animalis | Unchanged Inflammatory Response | Neutral | Small |
Bifidobacterium animalis subsp. lactis | Increased Polyamine Levels | Beneficial | Moderate |
Bifidobacterium animalis subsp. lactis BB-12 | Increased Intestinal Polyamine Levels | Beneficial | Moderate |
Bifidobacterium animalis subsp. lactis BB-12 | Maintained Gut Microbiota Composition | Neutral | Small |
Bifidobacterium animalis subsp. lactis BB-12 | Unchanged Inflammatory Response | Neutral | Small |
Bifidobacterium animalis subsp. lactis BS-01 | Enhanced Inflammatory Response | Neutral | Small |
Bifidobacterium animalis subsp. lactis BS-01 | Increased Polyamine Levels | Beneficial | Moderate |
Bifidobacterium animalis subsp. lactis VK2 | Increased Polyamine Levels | Beneficial | Moderate |
Bifidobacterium animalis subsp. lactis VK2 | Stable Inflammatory Responses | Neutral | Small |
Bifidobacterium bifidum BB01 | Increased Intestinal Polyamine Levels | Beneficial | Moderate |
Bifidobacterium bifidum BB01 | Unchanged Inflammatory Marker Production | Neutral | Small |
Bifidobacterium bifidum/lactis Bb-02 | Increased Polyamine Levels | Beneficial | Moderate |
Bifidobacterium bifidum/lactis Bb-02 | Unchanged Inflammatory Response | Neutral | Small |
Bifidobacterium lactis | Increased Intestinal Polyamine Levels | Beneficial | Moderate |
Bifidobacterium lactis | Unchanged Inflammatory Response | Neutral | Small |
Bifidobacterium lactis Bb-02 | Increased Polyamine Levels | Beneficial | Moderate |
Bifidobacterium lactis Bb-02 | Unchanged Inflammatory Response | Neutral | Small |
Bifidobacterium lactis BB-12 | Increased Intestinal Polyamine Levels | Beneficial | Moderate |
Bifidobacterium lactis Bi-07 | Increased Polyamine Levels | Beneficial | Moderate |
Bifidobacterium lactis Bi-07 | Unchanged Inflammatory Response | Neutral | Small |
Bifidobacterium lactis Bl-04 | Increased Polyamine Levels | Beneficial | Moderate |
Bifidobacterium lactis Bl-04 | No Change in Inflammatory or Anti-inflammatory Cytokine Levels | Neutral | Small |
Bifidobacterium lactis Bl-04 | Stable Bacterial Populations | Neutral | Small |
Bifidobacterium lactis BLA80 | Increased Polyamine Levels | Beneficial | Moderate |
Bifidobacterium lactis BLA80 | Unchanged Inflammatory Response | Neutral | Small |
Bifidobacterium lactis DSM 15954 | Increased Polyamine Levels | Beneficial | Moderate |
Bifidobacterium lactis DSM 15954 | Stable Bacterial Populations | Neutral | Small |
Bifidobacterium lactis DSM 15954 | Unchanged Inflammatory Response | Neutral | Small |
Bifidobacterium lactis ISS Bif | Increased Polyamine Levels | Beneficial | Moderate |
Bifidobacterium lactis ISS Bif | No Significant Change in Inflammatory Responses | Neutral | Small |
Bifidobacterium lactis MAK16B42L | Increased Intestinal Polyamine Levels | Beneficial | Moderate |
Bifidobacterium lactis MAK16B42L | Maintained Polyamine Levels | Beneficial | Small |
Bifidobacterium lactis MAK16B42L | Unchanged Gut Microbiota Composition | Neutral | Small |
Bifidobacterium lactis MAK16B42L | Unchanged Inflammatory Marker Levels | Neutral | Small |
Bifidobacterium lactis R101-8 | Increased Polyamine Levels | Beneficial | Moderate |
Bifidobacterium lactis R101-8 | Stable Inflammatory Responses | Neutral | Small |
Bifidobacterium lactis UABla-12 | Increased Intestinal Polyamine Levels | Beneficial | Moderate |
Bifidobacterium lactis UABla-12 | Unchanged Inflammatory Response | Neutral | Small |